Summary
The responses of the isolated canine pulmonary vein to guanabenz and to potassium chloride (KCl) were examined by means of the cannula-inserting method. The vessel was perfused by Krebs-Ringer bicarbonate solution at a constant flow rate at 37°C. In the early stage (within 2–3 hours of the perfusion period), guanabenz induced a dose-dependent vasoconstriction, whereas high doses of KCl caused, at most, a slight vasoconstriction. At the late stage (within 8–11 hours of the perfusion period), the dose-response curve for guanabenz was shifted to the left and the maximum response became approximately 3-fold larger than that in the early stage. Vasoconstriction in response to KCl was observed in 8 out of 11 preparations (73%) in the late stage. In both early and late stages, guanabenz-induced responses were similarly antagonized by DG-5128 (a selective α2-adrenoceptor antagonist) but not by bunazosin (a selective α1-adrenoceptor antagonist). Diltiazem caused an inhibition of guanabenz-induced constrictions, particularly in the late stage. KCl-induced vasoconstriction was not affected by bunazosin or DG-5128, but was markedly suppressed by diltiazem. In preparations in which the endothelium was removed by intraluminal treatment with saponin, the changes in guanabenz- and KCl-induced responses, which were dependent on the perfusion time, were not modified in either stage.
Our results suggest that α2-adrenoceptor-mediated vasoconstriction is enhanced in a perfusion-time-dependent manner in the isolated and perfused canine pulmonary vein. These enhanced responses mediated by latent α2-adrenoceptors are dependent on the influx of extracellular calcium ions. Because the removal of endothelial cells by saponin did not affect the time-dependent enhancement of the response to guanabenz, the removal of endothelial cells by prolonged perfusion may play little part in the time-dependent enhancement of the α2-adrenoceptor-mediated response.
Similar content being viewed by others
References
Langer SZ (1974) Presynaptic regulation of cathecholamine release. Biochem Pharmacol 23: 1793–1800
Berthelsen S, Pettinger WA (1977) A functional basis for classification of α-adrenergic receptors. Life Sci 21: 595–606
Drew GM, Whiting SB (1979) Evidence for two distinct types of postsynaptic α-adrenoceptor in vascular smooth muscle in vivo. Br J Pharmacol 67: 207–215
Hyman AL, Kadowitz PJ (1985) Evidence for existence of postjunctional α1- and α2-adrenoceptors in cat pulmonary vascular bed. Am J Physiol 249: H891-H898
Shebuski RJ, Fujita T, Ruffolo RR Jr (1986) Evaluation of alpha-1 and alpha-2 adrenoceptor-mediated vasoconstriction in the in situ, autoperfused, pulmonary circulation of the anesthetized dog. J Pharmacol Exp Ther 238: 217–223
Ruffolo RR Jr, Yaden EL, Waddell JE (1980) Receptor interactions of imidazolines. V. Clonidine differentiates postsynaptic alpha adrenergic receptor subtypes in tissues from the rat. J Pharmacol Exp Ther 213: 557–561
Drew GM (1980) Postsynaptic α2-adrenoceptors mediate pressor responses to 2-N,N-dimethylamino-5,6-dihydroxy-1,2,3,4-tetrahydronaphthalene (M-7). Eur J Pharmacol 65: 85–87
De Mey J, Vanhoutte PM (1981) Uneven distribution of postjunctional alpha1- and alpha2-like adrenoceptors in canine arterial and venous smooth muscle. Circ Res 48: 875–884
Ito T, Chiba S (1985) Existence of two types of postjunctional alpha adrenoceptors in the isolated canine intermediate auricular artery. J Pharmacol Exp Ther 234: 698–702
Han C, Abel PW, Minneman KP (1987) α1-Adrenoceptor subtypes linked to different mechanisms for increasing intracellular Ca2+ in smooth muscle. Nature 329: 333–335
Bylund DB (1981) Comparison of [3H]clonidine and [3H]yohimbine binding: Possible subtypes of alpha-2 adrenergic receptors. Pharmacologist 23: 215
Bylund DB (1985) Heterogeneity of alpha-2 adrenergic receptors. Pharmacol Biochem Behav 22: 835–843
Cheung Y-D, Barnett DB, Nahorski SR (1982) [3H]Rauwolscine and [3H]yohimbine binding to rat cerebral and human platelet membranes: Possible heterogeneity of α2-adrenoceptors. Eur J Pharmacol 84: 79–85
Bylund DB, Ray-Prenger C, Murphy TJ (1988) Alpha-2A and alpha-2B adrenergic receptor subtypes: Antagonist binding in tissues and cell lines containing only one subtype. J Pharmacol Exp Ther 245: 600–607
Haniuda M, Chiba S (1989) Time-dependent enhancement of xylazine-induced vasoconstriction in isolated and perfused canine pulmonary vein. J Pharmacol Exp Ther 249: 340–347
Langer SZ (1980) Presynaptic regulation of the release of cathecholamines. Pharmacol Rev 32: 337–362
Tsuji T, Chiba S (1984) Potentiating effect of methysergide on norepinephrine-induced constriction of the isolated internal carotid artery of the dog. Jpn J Pharmacol 34: 95–100
Chiba S, Tsukada M (1986) Comparison of vasoconstrictor actions of norepinephrine and potassium chloride before and after damage of endothelium by saponin. Heart Vessels 2: 1–5
Shoji T, Tsuru H, Shigei T (1983) A regional difference in the distribution of postsynaptic alpha-adrenoceptor subtypes in canine veins. Naunyn Schmiedebergs Arch Pharmacol 324: 246–255
Shebuski RI, Ohlstein EH, Smith JM, Ruffolo RR Jr (1987) Enhanced pulmonary alpha-2 adrenoceptor responsiveness under conditions of elevated pulmonary vascular tone, J Pharmacol Exp Ther 242: 158–165
Hyman Al, Kadowitz PJ (1986) Enhancement ofα- andβ-adrenoceptor responses by elevations in vascular tone in pulmonary circulation. Am J Physiol 250: H1109-H1116
Joiner PD, Kadowitz PJ, Hughes JP, Hyman AL (1975) NE and ACh responses of intrapulmonary vessels from dog, swine, sheep, and man. Am J Physiol 228: 1821–1827
Chiba S, Tsuji T (1985) Vascular responsiveness of isolated, perfused basilar arteries in dogs and monkeys. Tohoku J Exp Med 146: 363–370
Nakane T, Chiba S (1988) Comparative study of direct coronary vascular responses to diltiazem, adrenergicβ-blockers and other vasodilators in isolated, perfused dog and monkey coronary arteries. Arch Int Pharmacodyn Ther 291: 153–162
Chiba S, Kawai K (1987) Responses of isolated canine and simian femoral arteries and veins to phenylephrine, xylazine and KCl after removal of endothelium. J Auton Pharmacol 7: 3–10
Van Zwieten PA, Van Meel JCA, Timmermans PBMWM (1982) Calcium antagonists andα 2-adrenoceptors: Possible role of extracellular calcium ions inα 2-adrenoceptor-mediated vasoconstriction. J Cardiovasc Pharmacol 4: S273-S279
Cavero I, Shepperson N, Lefevre-Borg F, Langer SZ (1983) Differential inhibition of vascular smooth muscle responses toα 1- andα 2-adrenoceptor agonists by diltiazem and verapamil. Circ Res 52 (Suppl. I): 69–76
Godfraind T, Miller RC, Socrates Rima J (1982) Selectiveα 1- andα 2-adrenoceptor agonist-induced contractions and45Ca fluxes in the rat isolated aorta. Br J Pharmacol 77: 597–604
Verbeuren TJ, Jordaens FH, Bult H, Herman AG (1988) The endothelium inhibits the penetration of serotonin and norepinephrine in the isolated canine saphenous vein. J Pharmacol Exp Ther 244: 276–282
Rimele TJ, Vanhoutte PM (1983) Effects of inhibitors of arachidonic acid metabolism and calcium entry on responses to acetylcholine, potassium and norepinephrine in the isolated canine saphenous vein. J Pharmacol Exp Ther 225: 720–728
Miller VM, Vanhoutte PM (1985) Endothelialα 2-adrenoceptors in canine pulmonary and systemic blood vessels. Eur J Pharmacol 118: 123–129
Kenakin TP (1984) The relative contribution of affinity and efficacy to agonist activity: organ selectivity of noradrenaline and oxymetazoline with reference to the classification of drug receptors. Br J Pharmacol 81: 131–141
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Haniuda, M., Chiba, S. Perfusion-time dependent enhancements of guanabenz- and KCl-induced vasoconstrictions in isolated and perfused dog pulmonary veins. Heart Vessels 5, 212–218 (1990). https://doi.org/10.1007/BF02058692
Issue Date:
DOI: https://doi.org/10.1007/BF02058692